Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus

Emily A. Smitherman and Randy Q. Cron
The Journal of Rheumatology September 2021, 48 (9) 1355-1357; DOI: https://doi.org/10.3899/jrheum.210024
Emily A. Smitherman
1E.A. Smitherman, MD, MS, Assistant Professor, R.Q. Cron, MD, PhD, Professor, Division of Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emily A. Smitherman
  • For correspondence: Emily.Smitherman@peds.uab.edu
Randy Q. Cron
1E.A. Smitherman, MD, MS, Assistant Professor, R.Q. Cron, MD, PhD, Professor, Division of Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Randy Q. Cron
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Information

vol. 48 no. 9 1355-1357
DOI 
https://doi.org/10.3899/jrheum.210024
PubMed 
34329185

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online September 1, 2021.

Article Versions

  • Latest version (June 15, 2021 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021

Author Information

  1. Emily A. Smitherman1⇑ and
  2. Randy Q. Cron1
  1. 1E.A. Smitherman, MD, MS, Assistant Professor, R.Q. Cron, MD, PhD, Professor, Division of Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  1. Address correspondence to Dr. E.A. Smitherman, The Children’s Hospital, CPP N G10, 1600 7th Ave S, Birmingham, AL 35223-1711, USA. Email: Emily.Smitherman{at}peds.uab.edu.

Article usage

Article usage: June 2021 to June 2025

AbstractFullPdf
Jun 2021464062
Jul 202194025
Aug 2021985104
Sep 20213821371102
Oct 202110896978
Nov 20215073838
Dec 20213775916
Jan 20222738931
Feb 2022314198
Mar 20223631417
Apr 20221719625
May 20221617922
Jun 20221328313
Jul 2022933010
Aug 2022822318
Sep 20221331319
Oct 20221213013
Nov 202285313
Dec 202252073
Jan 20231037918
Feb 2023123423
Mar 202373849
Apr 202393317
May 2023634517
Jun 2023733817
Jul 2023638112
Aug 2023838223
Sep 2023531214
Oct 2023817116
Nov 2023617214
Dec 2023218111
Jan 2024928115
Feb 2024113025
Mar 2024317610
Apr 202451816
May 202401215
Jun 202451828
Jul 202422025
Aug 202431913
Sep 2024112618
Oct 202432428
Nov 202462828
Dec 20240813
Jan 202521011
Feb 2025141919
Mar 202571216
Apr 20257138
May 20252105
Jun 2025152133

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 48, Issue 9
1 Sep 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus
Emily A. Smitherman, Randy Q. Cron
The Journal of Rheumatology Sep 2021, 48 (9) 1355-1357; DOI: 10.3899/jrheum.210024

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus
Emily A. Smitherman, Randy Q. Cron
The Journal of Rheumatology Sep 2021, 48 (9) 1355-1357; DOI: 10.3899/jrheum.210024
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in Giant Cell Arteritis?
  • Understanding Fatigue and Sleep Disturbance in Polymyalgia Rheumatica: Redefining the Patient Experience and Opportunities for Intervention
  • The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire